Mitapivat
Agios Pharmaceuticals (AGIO)
Decision dateFeb 1, 2027
78 days away
Marketer take
Date moved from Nov 1, 2026 while FDA weighs whether a REMS is needed, which could shape how the brand is marketed and dispensed.
- Sponsor company
- Agios Pharmaceuticals (AGIO)
- Indication
- Sickle cell disease (accelerated approval sNDA)
- Therapeutic area
- Hematology
- Event
- PDUFA target action date
- Date
- Feb 1, 2027
- Previous date
- Nov 1, 2026 (moved)
- Status
- Delayed
- Source
- SEC filing
- Last verified
- Nov 15, 2026
Dates and status come from the linked public source as of the last verified date. Spot an error or have an update?